基本信息
浏览量:653
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
I am very involved in clinical trials, particularly those of targeted drugs known as kinase inhibitors, which block pathways inside cancer cells that cause the cells to grow or spread. One area of focus in my research is studying patients who are known as extraordinary responders. These are people with difficult-to-treat cancers who are found to respond exceptionally well to a new drug, even though that drug does not work in most people with the same disease.
研究兴趣
论文共 923 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
crossref(2024)
Xinnong Li,Mark Sale,Keith Nieforth, James Craig, Fenggong Wang,David Solit,Kairui Feng,Meng Hu,Robert Bies, Liang Zhao
Journal of Pharmacokinetics and Pharmacodynamicspp.1-12, (2024)
Cancer Researchno. 6_Supplement (2024): 1757-1757
biorxiv(2024)
Urologic Oncology: Seminars and Original Investigations (2024)
Nature Reviews Clinical Oncologyno. 3 (2024): 224-247
Trends in Cancer (2024)
Naitao Wang,Mohini Pachai, Dan Li,Cindy Lee,Sarah Warda, Makhzuna Khudoynazarova, Woo Hyun Cho,Guojia Xie, Fengshen Kuo,Sagar Shah,Li Yao, Cheng Qian,
Clinical Cancer Researchno. 10_Supplement (2024)
Neeta D'Souza,Manuel De Jesus Escano, Syed Muneeb Alam,Sizhi Gao,Xinran Tang,Alvin Goh,Bernard H. Bochner,David Solit,Gopakumar Iyer,Hikmat Al-Ahmadie,Eugene Pietzak, Priya Dave
Urologic Oncology: Seminars and Original Investigations (2024)
GYNECOLOGIC ONCOLOGY (2024): 162-169
加载更多
作者统计
#Papers: 927
#Citation: 63558
H-Index: 124
G-Index: 247
Sociability: 8
Diversity: 3
Activity: 394
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn